Abstract:Objective To investigate prognostic factors of more than 10 years of survival for liver cancer patients after liver transplantation. Methods From May 2000 to May 2007, a total of 134 liver cancer patients who underwent liver transplantation in the Department of Hepatobiliary Surgery, Peking University People’s Hospital, were continuously and retrospectively enrolled. The patients included 120 males and 14 females. There were 124 cases (92.5%) of primary hepatocellular carcinoma, 9 cases (6.7%) of cholangiocarcinoma, and 1 case of mixed hepatocellular carcinoma and cholangiocarcinoma. Patients with perioperative death were excluded. Follow-up was performed until May 31st, 2017 or the time of death. According to the data on postoperative survival time, patients were divided into a < 10 years group (81 cases) and a ≥ 10 years group (53 cases). Patients’ clinical data were recorded and analyzed, including alpha-fetoprotein (AFP) level (≥ 400 µg/L or < 400 µg/L), number of tumor lesions (< 3 or ≥ 3), tumor size (≤ 5 cm or > 5 cm), vascular tumor thrombus (large blood vessel or non-large blood vessel), and histological differentiation degree. The Kaplan–Meier method was used to calculate survival rates. The log-rank method was used to compare the differences between survival curves. The Cox proportional hazards regression model was used to perform multivariate analyses of possibly influential factors. Results (1) Follow-up was conducted with all 134 liver cancer patients after liver transplantation. The follow-up periods were 1–201 months, with a median of 18 (8.75, 132.5) months. The Kaplan–Meier survival analysis results showed that the 1-year, 3-year, 5-year, and 10-year cumulative survival rates were 70.3%, 48.6%, 46.8%, and 46.8%, respectively. (2) The differences in the age of patients, the incidence rate of AFP ≥ 400 µg/L, tumor histological differentiation, vascular tumor thrombi, tumor lesion size, and number of tumor lesions between two groups were all statistically significant (all P < 0.01). (3) The cumulative survival rates were different in AFP (log-rank χ 2 = 13.428), histopathologic differentiation (log-rank χ 2 = 33.592), large blood vessel tumor thrombi (log-rank χ 2 = 36.470), tumor lesion size (log-rank χ 2 = 39.835), and number of tumor lesions (log-rank χ 2 = 47.016), and there were statistically significant differences between groups (all P < 0.01). (4) Multivariate Cox proportional hazards regression analyses showed that ≥ 3 tumor lesions [hazard ratio (HR) = 2.879, 95% confidence interval (CI) 1.566–5.422], tumor lesion size > 5 cm (HR = 2.682, 95% CI 1.382–5.366), large blood vessel tumor thrombi (HR = 1.831, 95% CI 1.010–3.341), and poor histological differentiation (HR = 2.150, 95% CI 1.372–3.394), were risk factors affecting the 10-year survival of liver cancer patients after liver transplantation (all P < 0.05). Conclusion Tumor size, tumor number, large blood vessel tumor thrombi, and low tumor differentiation were all found to be independent risk factors affecting the 10-year survival rate after liver transplantation in liver cancer patients.

Analysis of survival and prognostic factors of liver transplantation for hepatocellular carcinoma

Relationship Between Clinicopathologic Features and Neoplasm Recurrence,prognosis in Hepatocellular Carcinoma after Liver Transplantation

Clinical Analysis of 67 Cases of Liver Transplantation for Hepatocellular Carcinoma

Analysis of Postoperative Survival and Prognostic Factors of Orthotopic Liver Transplantation for Hepatocellular Carcinoma Beyond UCSF Criteria

[Liver Transplantation for Hepatocellular Carcinoma: Prognostic Analysis of 89 Cases].

Liver Transplantation for Patients with Hepatocellular Carcinoma at the Liver Cancer Institute of Fudan University, China.

[Liver Transplantation for Treating Hepatocellular Carcinoma].

Survival analysis of 89 cases of liver transplantation for primary hepatic carcinoma

Role of Pittsburgh Modified TNM Criteria in Prognosis Prediction of Liver Transplantation for Hepatocellular Carcinoma.

The analysis of the post-orthotopic liver transplantation operation of 27 patients with primary hepatocellular carcinoma with portal vein tumor thrombi

Liver Transplantation for Hepatocellular Carcinoma:A Report of 60 Cases

[Multivariate Analysis of Recurrence of Hepatocellular Carcinoma after Liver Transplantation].

Analysis of the Risk Factors Influencing the Prognosis of Orthotopic Liver Transplantation for Hepatocellular Carcinoma and Summary of Relevant Clinical Experience

[Influence of Tumor Characteristics on the Outcome of Liver Transplantation among Patients with Hepatocellular Carcinoma].

Clinical Analysis of 36 Cases of Primary Hepatocellular Carcinoma with Liver Transplantation

Human leukocyte antigen-G and prognosis of liver transplantation in patients with hepatocellular carcinoma

Prognostic role of biomarkers applied to hepatocellular carcinoma patients treated with orthotopic liver transplantation

Analysis of prognostic factors of more/equal to10 years of survival for liver cancer patients after liver transplantation

A Single‐center Retrospective Analysis of Liver Transplantation on 255 Patients with Hepatocellular Carcinoma

Tumor size assessment with ultrasound as a prognostic factor for patients with liver transplantation for hepatocellular carcinoma

Prognostic Factors in Patients Underwent Hepatectomy for Large Hepatocellular Carcinoma